PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008 2009
ACTIVITY DESCRIPTION:
ASM has the capacity to support the PEPFAR program by ensuring that laboratories possess the necessary
organizational and technical infrastructure to provide quality laboratory testing and results in support of
tuberculosis (TB) diagnosis. ASM can provide technical assistance through carefully chosen experts from
among ASM's more than 5,000 clinical laboratory microbiologists and immunologists worldwide.
For COP08, ASM will focus on improving the quality and capacity of TB diagnosis in Nigeria. ASM will
provide technical assistance to the National TB Reference Lab (Lagos) and the National TB Training Center
(Zaria) through a lab director mentoring program. Both of these labs are developing automated TB culture
and drug sensitivity capacity. Two former TB lab directors will be selected by ASM to work closely with
reference lab directors over a 2-3 month period. Mentors will assist with development of a work plan, staff
training, creation of a quality assurance (QA) program and will provide assistance on lab safety issues.
ASM will work closely with PEPFAR-Nigeria Lab Technical Working Group (LTWG) to ensure that these
activities are coordinated with the (Government of Nigeria) GON and those organizations currently
supporting TB diagnosis and treatment in Nigeria (including, UMD-ACTION, Harvard-APIN, German
Leprosy Group, GHAIN, Netherlands Leprosy Group, Damien Foundation of Belgium (DFB) and WHO).
ASM will work through the LTWG to ensure that activities and deliverables are developed and implemented
in a harmonized fashion.
ASM is providing additional support for TB diagnosis; this is discussed in Lab Infrastructure narrative.
CONTRIBUTIONS TO OVERALL PROGRAM AREA:
ASM will contribute nationally to TB diagnostic programs through development of a QA program at two
reference labs and improvements to laboratory training programs.
LINKS TO OTHER ACTIVITIES:
An improved TB diagnostic program, directed at HIV infected individuals, results in stronger palliative care
program (HBHC-3.3.06 and HVTB-3.3.07).
POPULATIONS BEING TARGETED:
ASM will develop/improve training programs provided to laboratorians working in clinical health care
facilities for improved diagnosis of TB. ASM will also improve the infrastructure of laboratories where these
individuals currently work.
EMPHASIS AREAS:
The emphasis of this activity is local organizational capacity development in quality assurance and quality
improvement of laboratory testing.
This is a continuing activity funded in late COP07, with no funding planned for COP08 at present in HLAB.
organizational and technical infrastructure to provide quality laboratory testing and results in support of HIV
prevention, care, and treatment programs, especially for tuberculosis (TB) and opportunistic infections (OI).
ASM can provide technical assistance through carefully chosen experts from among ASM's more than
5,000 clinical laboratory microbiologists and immunologists worldwide.
For COP08, ASM will focus on improving the quality and capacity of TB and OI diagnosis in Nigeria. The
following five activities will support this goal: 1) development of a comprehensive quality assurance (QA)
and quality control (QC) system for TB microscopy and culture, reviewing the existing guidelines on QA for
AFB microscopy and developing such for TB culture/DST, 2) review and make improvements to the TB
training curriculum (and SOP's) currently used in Nigeria, 3) provision of technical expertise on the
structural design of new and existing laboratories involved in diagnosis of TB (specifically, culture and drug
resistance testing), 4) improvement of training for simple OI diagnosis (microscopy) and 5) support training
on TB culture and drug sensitivity within a TB reference lab in South Africa for a PEPFAR-Nigeria
laboratorian. ASM will work closely with PEPFAR-Nigeria Lab Technical Working Group (LTWG) to ensure
that these activities are coordinated with the (Government of Nigeria) GON and those organizations
currently supporting TB diagnosis and treatment in Nigeria (including, UMD-ACTION, Harvard-APIN,
German Leprosy Group, GHAIN, Netherlands Leprosy Group, Damien Foundation of Belgium (DFB) and
WHO). ASM will work through the LTWG to ensure that activities and deliverables are developed and
implemented in a harmonized fashion.
ASM will contribute nationally to TB and OI diagnostic programs through development of a QA program,
improvements to laboratory training programs and improved lab infrastructure at all TB diagnostic and
treatment facilities.
Improved TB and OI diagnosis programs directed at HIV infected individuals, results in a stronger palliative
care program (HBHC-3.3.06 and HVTB-3.3.07).
facilities for improved diagnosis of TB and OI. ASM will also improve the infrastructure of laboratories where
these individuals currently work.
EMPHASIS AREAS: The emphasis of this activity is local organizational capacity development in quality
assurance and quality improvement of laboratory testing.
